Am J Med. 2018 Sep 18. pii: S0002-9343(18)30872-6. doi: 10.1016/j.amjmed.2018.09.006.
[Epub ahead of print]
Abstract
The recent Federal Drug Administration approval of the marijuana constituent cannabidiol (CBD) as safe and effective for treatment of two rare forms of epilepsy, has raised hopes that others of the 500 chemicals in marijuana will be found to be therapeutic. However, the long term consequences of street marijuana use are unclear and recent studies raise red flags about its effects. Changes in brain maturation and intellectual function including decreases in intelligence quotient have been noted in chronic users and appear permanent in early users in most but not all studies. These studies suggest that at a minimum, regular marijuana use should be discouraged in individuals under the age of 21.
KEYWORDS:
adolescents; brain development; marijuana; teenager
- PMID: 30240677
- DOI: 10.1016/j.amjmed.2018.09.006
-
Publication type
Publication type